Clinical Trial Update: A Prospective Multi-center Phase III Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A Phase III randomized controlled trial update is reported for non-small cell lung carcinoma, with status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Carcinoma，Non-Small-Cell Lung | Phase 3 | Status: UNKNOWN